Podcasts

Join us for this two-episode mini-series featuring lead study authors, Mario Castro and Njira Lugogo, as they discuss key findings from the…

How is the breast cancer landscape evolving, from HER2-low breakthroughs to the future of targeted therapy and precision care?

Catherine Glass sits down with leading diabetes researcher Vinod Patel to discuss the future of Type 2 diabetes care, exploring new technologies, predictive tools, retinal imaging, and much more.

Emanuele Angelucci shares the latest on cellular therapies, gene therapy, and breakthroughs in treating haemoglobinopathies.

In this deeply personal episode, Jonathan Sackier speaks with Zoe Strickland, author of To Grief With Love, about how she navigated the loss of her son and found space for healing through creative expression and connection.

How if scientific innovation transforming precision oncology? Simon Lord, Associate Professor in Experimental Cancer Therapeutics at the University of Oxford shares his expertise.

Explore the evolving role of methotrexate (MTX) in rheumatoid arthritis (RA) care in this expert-led podcast featuring leading…

What is the link between pain and anxiety? David Cosio, Clinical Psychologist, Interdisciplinary Pain Program, Jesse Brown VA Medical, Chicago, Illinois, USA, shares the latest advances in pain management and more.

Discover the complexities of pulmonary arterial hypertension (PAH) with Neal Chaisson, Assistant Professor of Medicine at the Cleveland Clinic.

Steven Okoli, Honorary Senior Clinical Lecturer at Imperial College London, shares how AI, advocacy, and stem cell trials are driving the next chapter in sickle cell care.

In the first episode of our Rare Lung Diseases podcast series, host Saranya Ravindran speaks with James Stoller, Cleveland Clinic, about Alpha-1 antitrypsin deficiency, a rare genetic condition that is frequently underdiagnosed.

In this episode Jonathan is joined by Jean Abraham, to delve into the future of integrated cancer medicine, the evolving role of clinical trials, and how precision oncology is redefining outcomes for patients with breast cancer across the UK.

Claudio Cerchione explores advances in multiple myeloma, MRD, and CAR-T therapy, with key insights from EHA and ASCO in this Hema Now episode.

In this three-part series, Jonathan Sackier sits down with Professor Zoë Paskins to explore the complexities and advancements in rheumatology and bone health.

In this podcast, Kenneth Alexander and Jorg Schelling, experts in the fields of infectious disease and family medicine, respectively…

Kevin Rouault-Pierre and Onima Chowdhury explore the molecular roots of myelodysplastic syndromes (MDS), and their implications for future care.

Discover the growing impact of environmental factors on men’s health – from the risks of microplastics to the benefits of plant-based diets, and much more

In the third episode of our lung cancer miniseries, Jonathan Sackier is joined by Douglas E. Wood to explore the critical role of lung cancer staging, the evolution of screening guidelines, and more.

Lennard Lee, Associate Professor of Cancer Vaccines at the University of Oxford, shares how large-scale collaboration is shaping the future of cancer vaccines and oncology innovation.

Lydia Scarfò discusses types of leukaemia, current treatment approaches, recent advances, and future possibilities.

This week, the host Saranya Ravindran welcomes Tommaso Falcone, reproductive health pioneer and global healthcare leader. From redefining…

In this second episode of our lung cancer miniseries, Jonathan Sackier is joined by David Baldwin, a leading expert in screening, epidemiology, and policy.

Podcast series on Becker Muscular Dystrophy (BMD), exploring diagnosis, disease progression, treatment and…

Bradley Monk, Medical Director of Late-Phase Clinical Research at Florida Cancer Specialists, shares key understandings from the Society of Gynecologic Oncology (SGO) 2025, alongside a fascinating deep dive into drug approval and access.